Top Biotechnology companies in Germany by Free Cash Flow

This ranking features the top 18 Biotechnology companies in Germany ranked by Free Cash Flow, totaling a Free Cash Flow of USD 8.71 B, for June 17, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue EBIT EBITDA Net Income Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Biotechnology company in Germany has the highest Free Cash Flow ?

The Biotechnology company in Germany with the highest Free Cash Flow is Bayer AG (XETRA: BAYN.DE) at USD 4.75 B.
Which Biotechnology company in Germany has the lowest Free Cash Flow ?

The Biotechnology company in Germany with the lowest Free Cash Flow is Atai Life Sciences N.V. (NasdaqGM: ATAI) at None.

What are the top 10 Biotechnology companies in Germany by Free Cash Flow ?

The top 10 Biotechnology companies in Germany by Free Cash Flow are Bayer AG, MERCK Kommanditgesellschaft auf Aktien, Siemens Healthineers AG, CureVac N.V., Eckert & Ziegler Strahlen- und Medizintechnik AG, Biotest AG, VITA 34 AG, Stratec SE, Anbio Biotechnology Class A Ordinary Shares and BRAIN Biotech AG.
What are the bottom 10 Biotechnology companies in Germany by Free Cash Flow ?

The bottom 10 Biotechnology companies in Germany by Free Cash Flow are Atai Life Sciences N.V., BioNTech SE, Immatics N.V., Evotec SE, Formycon AG, Heidelberg Pharma AG, Vivoryon Therapeutics N.V., Mainz Biomed B.V., BRAIN Biotech AG and Anbio Biotechnology Class A Ordinary Shares.